Form 4 holding
EVP, Research & CSO
Vir Biotechnology, Inc.
- Security class
- Common Stock
- Shares / value
- 262,500
- Estimated value
- $401,625
- Report date
- 09 Aug 2022
- Price
- $1.53
- Ownership
- Direct
Herbert Virgin - EVP, Research & CSO at Vir Biotechnology, Inc.
Issuer-level insider activity
- Role
- EVP, Research & CSO
- Issuer ticker
- VIR on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Herbert Virgin since 21 Sep 2025
Reported holdings for Herbert Virgin in Vir Biotechnology, Inc.
Form 4 holding
EVP, Research & CSO
Vir Biotechnology, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 125,416
- Estimated value
- $191,886
- Report date
- 09 Aug 2022
- Price
- $1.53
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Herbert Virgin in Vir Biotechnology, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.